Everest Medicines Limited (HKG:1952)

Everest Medicines Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,297	884.47	523.06	490.79	2,640	4,481
Short-Term Investments	289.28	718.84	1,827	1,161	-	2.08
Cash & Short-Term Investments	1,586	1,603	2,350	1,651	2,640	4,483
Cash Growth	-	-31.77%	42.29%	-37.45%	-41.11%	4120.60%
Accounts Receivable	300.87	363.57	49.86	5.21	0.05	-
Other Receivables	32.13	24.69	81.96	1,681	19.52	10.91
Receivables	333	388.26	131.81	1,687	19.57	10.91
Inventory	8.81	14.08	18.94	11.64	0.45	-
Other Current Assets	24.12	9.98	7.16	64.6	27.86	2.3
Total Current Assets	1,952	2,016	2,508	3,414	2,688	4,496
Property, Plant & Equipment	656.01	650.04	683.99	643.86	262.64	121.97
Long-Term Investments	59.29	29.71	48.93	89.24	830.4	845.7
Other Intangible Assets	2,241	2,254	2,524	2,378	2,471	2,006
Other Long-Term Assets	21.9	6.6	6.12	86.69	391.44	4.87
Total Assets	4,932	4,959	5,773	6,615	6,646	7,477
Accounts Payable	116.03	118.69	95.48	107.52	85.66	75.1
Accrued Expenses	105.64	151.36	73.51	182.07	133.79	87.62
Current Portion of Long-Term Debt	78.79	470.21	51.28	424.08	-	-
Current Portion of Leases	16.41	18.78	18.65	20.33	28.25	19.02
Other Current Liabilities	40.85	34.5	89.82	136.03	22.56	5.18
Total Current Liabilities	357.72	793.54	328.74	870.03	270.27	186.91
Long-Term Debt	606.92	55.85	429.31	30.92	387.71	390.32
Long-Term Leases	32.86	30.77	40	59.31	95.85	58.88
Long-Term Unearned Revenue	5.82	5.9	6.05	-	-	-
Other Long-Term Liabilities	2.47	-	-	-	-	-
Total Liabilities	1,006	886.05	804.1	960.26	753.83	636.11
Common Stock	0.22	0.22	0.22	0.21	0.2	0.2
Retained Earnings	-10,308	-10,058	-9,016	-8,172	-7,925	-6,916
Treasury Stock	-	-	-0	-0	-58.71	-
Comprehensive Income & Other	14,234	14,130	13,985	13,826	13,875	13,757
Shareholders' Equity	3,926	4,073	4,969	5,654	5,892	6,841
Total Liabilities & Equity	4,932	4,959	5,773	6,615	6,646	7,477
Total Debt	734.97	575.61	539.24	534.64	511.81	468.21
Net Cash (Debt)	850.93	1,028	1,810	1,117	2,128	4,015
Net Cash Growth	-	-43.23%	62.12%	-47.53%	-46.99%	-
Net Cash Per Share	2.63	3.20	5.78	3.75	7.26	47.04
Filing Date Shares Outstanding	327.43	324.35	319.36	305.46	294.41	293.22
Total Common Shares Outstanding	327.43	324.35	319.36	305.46	294.41	293.22
Working Capital	1,594	1,222	2,179	2,544	2,418	4,309
Book Value Per Share	11.99	12.56	15.56	18.51	20.01	23.33
Tangible Book Value	1,686	1,818	2,445	3,276	3,421	4,835
Tangible Book Value Per Share	5.15	5.61	7.66	10.72	11.62	16.49
Buildings	-	461.02	437.87	378.28	-	-
Machinery	-	179.16	167.32	84.66	5.72	1.65
Construction In Progress	-	-	9.79	45.75	102.91	5.92
Leasehold Improvements	-	48.17	46.9	44.77	15.91	9.98

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.